The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Latent Tuberculosis Infection Detection Market Research Report 2025
Synopsis
The main ways to diagnose LTBI are by placing a tuberculin skin test (TST) on the forearm or by getting a TB blood test, in addition to obtaining a chest radiograph (x-ray) if either one of these tests is positive. One-third of the world's population has LTBI. The TB germs are dormant (asleep) in the body.
Highlights
The global Latent Tuberculosis Infection Detection market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Latent Tuberculosis Infection Detection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Latent Tuberculosis Infection Detection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Latent Tuberculosis Infection Detection in Diagnostic Laboratories is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Latent Tuberculosis Infection Detection include Abbott, QIAGEN, F. Hoffmann-La Roche Ltd, Sanofi, Oxford Immunotec USA, ARKRAY, Inc. and bioMérieux SA, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Tuberculin Skin Test, which accounted for % of the global market of Latent Tuberculosis Infection Detection in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Latent Tuberculosis Infection Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latent Tuberculosis Infection Detection.
The Latent Tuberculosis Infection Detection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Latent Tuberculosis Infection Detection market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Latent Tuberculosis Infection Detection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Abbott
QIAGEN
F. Hoffmann-La Roche Ltd
Sanofi
Oxford Immunotec USA
ARKRAY, Inc.
bioMérieux SA
Product Type Insights
Global markets are presented by Latent Tuberculosis Infection Detection type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Latent Tuberculosis Infection Detection are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Latent Tuberculosis Infection Detection segment by Type
Tuberculin Skin Test
Interferon Gamma Release Assays
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Latent Tuberculosis Infection Detection market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Latent Tuberculosis Infection Detection market.
Latent Tuberculosis Infection Detection Segment by Application
Diagnostic Laboratories
Hospitals/Clinics
Academic & Research Institutions
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Latent Tuberculosis Infection Detection market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latent Tuberculosis Infection Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Latent Tuberculosis Infection Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Latent Tuberculosis Infection Detection industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latent Tuberculosis Infection Detection.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Latent Tuberculosis Infection Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The main ways to diagnose LTBI are by placing a tuberculin skin test (TST) on the forearm or by getting a TB blood test, in addition to obtaining a chest radiograph (x-ray) if either one of these tests is positive. One-third of the world's population has LTBI. The TB germs are dormant (asleep) in the body.
Highlights
The global Latent Tuberculosis Infection Detection market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Latent Tuberculosis Infection Detection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Latent Tuberculosis Infection Detection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The global market for Latent Tuberculosis Infection Detection in Diagnostic Laboratories is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global companies of Latent Tuberculosis Infection Detection include Abbott, QIAGEN, F. Hoffmann-La Roche Ltd, Sanofi, Oxford Immunotec USA, ARKRAY, Inc. and bioMérieux SA, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
Considering the economic change due to COVID-19, Tuberculin Skin Test, which accounted for % of the global market of Latent Tuberculosis Infection Detection in 2021, is expected to reach US$ million by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Latent Tuberculosis Infection Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Latent Tuberculosis Infection Detection.
The Latent Tuberculosis Infection Detection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Latent Tuberculosis Infection Detection market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Latent Tuberculosis Infection Detection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Abbott
QIAGEN
F. Hoffmann-La Roche Ltd
Sanofi
Oxford Immunotec USA
ARKRAY, Inc.
bioMérieux SA
Product Type Insights
Global markets are presented by Latent Tuberculosis Infection Detection type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Latent Tuberculosis Infection Detection are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Latent Tuberculosis Infection Detection segment by Type
Tuberculin Skin Test
Interferon Gamma Release Assays
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Latent Tuberculosis Infection Detection market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Latent Tuberculosis Infection Detection market.
Latent Tuberculosis Infection Detection Segment by Application
Diagnostic Laboratories
Hospitals/Clinics
Academic & Research Institutions
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Latent Tuberculosis Infection Detection market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Latent Tuberculosis Infection Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Latent Tuberculosis Infection Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Latent Tuberculosis Infection Detection industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Latent Tuberculosis Infection Detection.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Latent Tuberculosis Infection Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Latent Tuberculosis Infection Detection Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Tuberculin Skin Test
1.2.3 Interferon Gamma Release Assays
1.3 Market by Application
1.3.1 Global Latent Tuberculosis Infection Detection Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals/Clinics
1.3.4 Academic & Research Institutions
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Latent Tuberculosis Infection Detection Market Perspective (2017-2028)
2.2 Latent Tuberculosis Infection Detection Growth Trends by Region
2.2.1 Latent Tuberculosis Infection Detection Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Latent Tuberculosis Infection Detection Historic Market Size by Region (2017-2022)
2.2.3 Latent Tuberculosis Infection Detection Forecasted Market Size by Region (2023-2028)
2.3 Latent Tuberculosis Infection Detection Market Dynamics
2.3.1 Latent Tuberculosis Infection Detection Industry Trends
2.3.2 Latent Tuberculosis Infection Detection Market Drivers
2.3.3 Latent Tuberculosis Infection Detection Market Challenges
2.3.4 Latent Tuberculosis Infection Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Latent Tuberculosis Infection Detection Players by Revenue
3.1.1 Global Top Latent Tuberculosis Infection Detection Players by Revenue (2017-2022)
3.1.2 Global Latent Tuberculosis Infection Detection Revenue Market Share by Players (2017-2022)
3.2 Global Latent Tuberculosis Infection Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Latent Tuberculosis Infection Detection Revenue
3.4 Global Latent Tuberculosis Infection Detection Market Concentration Ratio
3.4.1 Global Latent Tuberculosis Infection Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Latent Tuberculosis Infection Detection Revenue in 2021
3.5 Latent Tuberculosis Infection Detection Key Players Head office and Area Served
3.6 Key Players Latent Tuberculosis Infection Detection Product Solution and Service
3.7 Date of Enter into Latent Tuberculosis Infection Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Latent Tuberculosis Infection Detection Breakdown Data by Type
4.1 Global Latent Tuberculosis Infection Detection Historic Market Size by Type (2017-2022)
4.2 Global Latent Tuberculosis Infection Detection Forecasted Market Size by Type (2023-2028)
5 Latent Tuberculosis Infection Detection Breakdown Data by Application
5.1 Global Latent Tuberculosis Infection Detection Historic Market Size by Application (2017-2022)
5.2 Global Latent Tuberculosis Infection Detection Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Latent Tuberculosis Infection Detection Market Size (2017-2028)
6.2 North America Latent Tuberculosis Infection Detection Market Size by Country (2017-2022)
6.3 North America Latent Tuberculosis Infection Detection Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Latent Tuberculosis Infection Detection Market Size (2017-2028)
7.2 Europe Latent Tuberculosis Infection Detection Market Size by Country (2017-2022)
7.3 Europe Latent Tuberculosis Infection Detection Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Latent Tuberculosis Infection Detection Market Size (2017-2028)
8.2 Asia-Pacific Latent Tuberculosis Infection Detection Market Size by Country (2017-2022)
8.3 Asia-Pacific Latent Tuberculosis Infection Detection Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Latent Tuberculosis Infection Detection Market Size (2017-2028)
9.2 Latin America Latent Tuberculosis Infection Detection Market Size by Country (2017-2022)
9.3 Latin America Latent Tuberculosis Infection Detection Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Latent Tuberculosis Infection Detection Market Size (2017-2028)
10.2 Middle East & Africa Latent Tuberculosis Infection Detection Market Size by Country (2017-2022)
10.3 Middle East & Africa Latent Tuberculosis Infection Detection Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Latent Tuberculosis Infection Detection Introduction
11.1.4 Abbott Revenue in Latent Tuberculosis Infection Detection Business (2017-2022)
11.1.5 Abbott Recent Development
11.2 QIAGEN
11.2.1 QIAGEN Company Detail
11.2.2 QIAGEN Business Overview
11.2.3 QIAGEN Latent Tuberculosis Infection Detection Introduction
11.2.4 QIAGEN Revenue in Latent Tuberculosis Infection Detection Business (2017-2022)
11.2.5 QIAGEN Recent Development
11.3 F. Hoffmann-La Roche Ltd
11.3.1 F. Hoffmann-La Roche Ltd Company Detail
11.3.2 F. Hoffmann-La Roche Ltd Business Overview
11.3.3 F. Hoffmann-La Roche Ltd Latent Tuberculosis Infection Detection Introduction
11.3.4 F. Hoffmann-La Roche Ltd Revenue in Latent Tuberculosis Infection Detection Business (2017-2022)
11.3.5 F. Hoffmann-La Roche Ltd Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Latent Tuberculosis Infection Detection Introduction
11.4.4 Sanofi Revenue in Latent Tuberculosis Infection Detection Business (2017-2022)
11.4.5 Sanofi Recent Development
11.5 Oxford Immunotec USA
11.5.1 Oxford Immunotec USA Company Detail
11.5.2 Oxford Immunotec USA Business Overview
11.5.3 Oxford Immunotec USA Latent Tuberculosis Infection Detection Introduction
11.5.4 Oxford Immunotec USA Revenue in Latent Tuberculosis Infection Detection Business (2017-2022)
11.5.5 Oxford Immunotec USA Recent Development
11.6 ARKRAY, Inc.
11.6.1 ARKRAY, Inc. Company Detail
11.6.2 ARKRAY, Inc. Business Overview
11.6.3 ARKRAY, Inc. Latent Tuberculosis Infection Detection Introduction
11.6.4 ARKRAY, Inc. Revenue in Latent Tuberculosis Infection Detection Business (2017-2022)
11.6.5 ARKRAY, Inc. Recent Development
11.7 bioMérieux SA
11.7.1 bioMérieux SA Company Detail
11.7.2 bioMérieux SA Business Overview
11.7.3 bioMérieux SA Latent Tuberculosis Infection Detection Introduction
11.7.4 bioMérieux SA Revenue in Latent Tuberculosis Infection Detection Business (2017-2022)
11.7.5 bioMérieux SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Latent Tuberculosis Infection Detection Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Tuberculin Skin Test
Table 3. Key Players of Interferon Gamma Release Assays
Table 4. Global Latent Tuberculosis Infection Detection Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Latent Tuberculosis Infection Detection Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Latent Tuberculosis Infection Detection Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Latent Tuberculosis Infection Detection Market Share by Region (2017-2022)
Table 8. Global Latent Tuberculosis Infection Detection Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Latent Tuberculosis Infection Detection Market Share by Region (2023-2028)
Table 10. Latent Tuberculosis Infection Detection Market Trends
Table 11. Latent Tuberculosis Infection Detection Market Drivers
Table 12. Latent Tuberculosis Infection Detection Market Challenges
Table 13. Latent Tuberculosis Infection Detection Market Restraints
Table 14. Global Latent Tuberculosis Infection Detection Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Latent Tuberculosis Infection Detection Market Share by Players (2017-2022)
Table 16. Global Top Latent Tuberculosis Infection Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection Detection as of 2021)
Table 17. Ranking of Global Top Latent Tuberculosis Infection Detection Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Latent Tuberculosis Infection Detection Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Latent Tuberculosis Infection Detection Product Solution and Service
Table 21. Date of Enter into Latent Tuberculosis Infection Detection Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Latent Tuberculosis Infection Detection Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Latent Tuberculosis Infection Detection Revenue Market Share by Type (2017-2022)
Table 25. Global Latent Tuberculosis Infection Detection Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Latent Tuberculosis Infection Detection Revenue Market Share by Type (2023-2028)
Table 27. Global Latent Tuberculosis Infection Detection Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Latent Tuberculosis Infection Detection Revenue Market Share by Application (2017-2022)
Table 29. Global Latent Tuberculosis Infection Detection Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Latent Tuberculosis Infection Detection Revenue Market Share by Application (2023-2028)
Table 31. North America Latent Tuberculosis Infection Detection Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Latent Tuberculosis Infection Detection Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Latent Tuberculosis Infection Detection Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Latent Tuberculosis Infection Detection Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Latent Tuberculosis Infection Detection Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Latent Tuberculosis Infection Detection Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Latent Tuberculosis Infection Detection Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Latent Tuberculosis Infection Detection Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Latent Tuberculosis Infection Detection Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Latent Tuberculosis Infection Detection Market Size by Country (2023-2028) & (US$ Million)
Table 41. Abbott Company Detail
Table 42. Abbott Business Overview
Table 43. Abbott Latent Tuberculosis Infection Detection Product
Table 44. Abbott Revenue in Latent Tuberculosis Infection Detection Business (2017-2022) & (US$ Million)
Table 45. Abbott Recent Development
Table 46. QIAGEN Company Detail
Table 47. QIAGEN Business Overview
Table 48. QIAGEN Latent Tuberculosis Infection Detection Product
Table 49. QIAGEN Revenue in Latent Tuberculosis Infection Detection Business (2017-2022) & (US$ Million)
Table 50. QIAGEN Recent Development
Table 51. F. Hoffmann-La Roche Ltd Company Detail
Table 52. F. Hoffmann-La Roche Ltd Business Overview
Table 53. F. Hoffmann-La Roche Ltd Latent Tuberculosis Infection Detection Product
Table 54. F. Hoffmann-La Roche Ltd Revenue in Latent Tuberculosis Infection Detection Business (2017-2022) & (US$ Million)
Table 55. F. Hoffmann-La Roche Ltd Recent Development
Table 56. Sanofi Company Detail
Table 57. Sanofi Business Overview
Table 58. Sanofi Latent Tuberculosis Infection Detection Product
Table 59. Sanofi Revenue in Latent Tuberculosis Infection Detection Business (2017-2022) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. Oxford Immunotec USA Company Detail
Table 62. Oxford Immunotec USA Business Overview
Table 63. Oxford Immunotec USA Latent Tuberculosis Infection Detection Product
Table 64. Oxford Immunotec USA Revenue in Latent Tuberculosis Infection Detection Business (2017-2022) & (US$ Million)
Table 65. Oxford Immunotec USA Recent Development
Table 66. ARKRAY, Inc. Company Detail
Table 67. ARKRAY, Inc. Business Overview
Table 68. ARKRAY, Inc. Latent Tuberculosis Infection Detection Product
Table 69. ARKRAY, Inc. Revenue in Latent Tuberculosis Infection Detection Business (2017-2022) & (US$ Million)
Table 70. ARKRAY, Inc. Recent Development
Table 71. bioMérieux SA Company Detail
Table 72. bioMérieux SA Business Overview
Table 73. bioMérieux SA Latent Tuberculosis Infection Detection Product
Table 74. bioMérieux SA Revenue in Latent Tuberculosis Infection Detection Business (2017-2022) & (US$ Million)
Table 75. bioMérieux SA Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Latent Tuberculosis Infection Detection Market Share by Type: 2021 VS 2028
Figure 2. Tuberculin Skin Test Features
Figure 3. Interferon Gamma Release Assays Features
Figure 4. Global Latent Tuberculosis Infection Detection Market Share by Application in 2021 & 2028
Figure 5. Diagnostic Laboratories Case Studies
Figure 6. Hospitals/Clinics Case Studies
Figure 7. Academic & Research Institutions Case Studies
Figure 8. Latent Tuberculosis Infection Detection Report Years Considered
Figure 9. Global Latent Tuberculosis Infection Detection Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Latent Tuberculosis Infection Detection Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Latent Tuberculosis Infection Detection Market Share by Region: 2021 VS 2028
Figure 12. Global Latent Tuberculosis Infection Detection Market Share by Players in 2021
Figure 13. Global Top Latent Tuberculosis Infection Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Latent Tuberculosis Infection Detection as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Latent Tuberculosis Infection Detection Revenue in 2021
Figure 15. North America Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Latent Tuberculosis Infection Detection Market Share by Country (2017-2028)
Figure 17. United States Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Latent Tuberculosis Infection Detection Market Share by Country (2017-2028)
Figure 21. Germany Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Latent Tuberculosis Infection Detection Market Share by Region (2017-2028)
Figure 29. China Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Latent Tuberculosis Infection Detection Market Share by Country (2017-2028)
Figure 37. Mexico Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Latent Tuberculosis Infection Detection Market Share by Country (2017-2028)
Figure 41. Turkey Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Latent Tuberculosis Infection Detection Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Abbott Revenue Growth Rate in Latent Tuberculosis Infection Detection Business (2017-2022)
Figure 44. QIAGEN Revenue Growth Rate in Latent Tuberculosis Infection Detection Business (2017-2022)
Figure 45. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Latent Tuberculosis Infection Detection Business (2017-2022)
Figure 46. Sanofi Revenue Growth Rate in Latent Tuberculosis Infection Detection Business (2017-2022)
Figure 47. Oxford Immunotec USA Revenue Growth Rate in Latent Tuberculosis Infection Detection Business (2017-2022)
Figure 48. ARKRAY, Inc. Revenue Growth Rate in Latent Tuberculosis Infection Detection Business (2017-2022)
Figure 49. bioMérieux SA Revenue Growth Rate in Latent Tuberculosis Infection Detection Business (2017-2022)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
